A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).

被引：29
|
作者：
Tchekmedyian, Vatche
Sherman, Eric Jeffrey
Dunn, Lara
Fetten, James Vincent
Michel, Loren S.
Kriplani, Anuja
Morris, Luc
Ostrovnaya, Irina
Katabi, Nora
Haque, Sofia
Tran, Crystal
Azar, Julian
Pfister, David G.
Ho, Alan Loh
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.6084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs).
    Burman, Bharat
    Sherman, Eric Jeffrey
    Dunn, Lara
    Fetten, James Vincent
    Michel, Loren S.
    Morris, Luc G. T.
    Ostrovnaya, Irina
    Haque, Sofia
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Axitinib plus avelumab for recurrent/metastatic adenoid cystic carcinoma (R/M ACC): Biomarker analysis of the phase II trial
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Mitani, Yoshitsugu
    Heeke, Simon
    Sousa, Luana
    Santos, Erison
    Siqueira, Juliana Mota
    Li, Kaiyi
    Bell, Diana
    Marques-Piubelli, Mario L.
    Lin, Shiaw-Yih
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).
    Dillon, Patrick Michael
    Petroni, Gina R.
    Moskaluk, Chris
    Fracasso, Paula M.
    Douvas, Michael G.
    Perez, Jose Ricardo
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Phase II study of sunitinib in patients (pts) with progressive metastatic adenoid cystic carcinoma (ACC)
    Hotte, S. J.
    Chen, E. X.
    Hirte, H. W.
    Moretto, P.
    Turner, S.
    Chin, S. F.
    Wang, L.
    MacAlpine, K.
    Siu, L. L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 65 - 65
  • [5] Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Heeke, Simon
    de Sousa, Luana Guimaraes
    Li, Kaiyi
    Bell, Diana
    Mitani, Yoshitsugu
    Marques-Piubelli, Mario L.
    Cortez, Maria Angelica
    Lin, Shiaw-Yih
    Elamin, Yasir Y.
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] A phase 2 clinical trial of axitinib and avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (ACC).
    Ferrarotto, Renata
    Bell, Diana
    Feng, Lei
    Li, Kaiyi
    Mott, Frank
    Blumenschein, George R.
    De Sousa, Luana Guimaraes
    Altan, Mehmet
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo Andreazza
    Kaya, Diana
    Godoy, Myrna
    Kupferman, Michael Elliot
    Glisson, Bonnie S.
    El-Naggar, Adel K.
    Elamin, Yasir Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Phase II study of nivolumab and ipilimumab for treatment of metastatic/recurrent adenoid cystic carcinoma (ACC) of all anatomic sites of origin and other malignant salivary gland tumors
    Chae, Young Kwang
    Duan, Richard
    Chung, Liam Il-Young
    Oh, Youjin
    Matsangou, Maria
    Agulnik, Mark
    Villaflor, Victoria
    Mahalingam, Devalingam
    CANCER RESEARCH, 2023, 83 (08)
  • [8] Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma
    Ferrarotto, Renata
    Sousa, Luana G.
    Feng, Lei
    Mott, Frank
    Blumenschein, George
    Altan, Mehmet
    Bell, Diana
    Bonini, Flavia
    Li, Kaiyi
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo A.
    Johnson, Jason J.
    Mitani, Yoshitsugu
    Godoy, Myrna
    Lee, Anna
    Kupferman, Michael
    Hanna, Ehab
    Glisson, Bonnie S.
    Elamin, Yasir
    El-Naggar, Adel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2843 - +
  • [9] Efficacy of NOTCH inhibitors (Ni) relative to prior systemic therapy or observation in patients (pts) with recurrent/ metastatic (R/M) adenoid cystic carcinoma (ACC)
    Hoff, C. O.
    de Sousa, L. G.
    Bonini, F.
    Dal Lago, E.
    Wang, K.
    Siqueira, J. Mota
    Cortez, M. A.
    Mitani, Y.
    Purushothaman, A.
    El-Naggar, A.
    Ferrarotto, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S577 - S578
  • [10] A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
    Dillon, Patrick M.
    Petroni, Gina R.
    Horton, Bethany J.
    Moskaluk, Christopher A.
    Fracasso, Paula M.
    Douvas, Michael G.
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4138 - 4145
12345